Member Info for uxm484

Big news on Valirx great for both PYC and VAL.

Val has been to 60/70p a few times this time when the deal completes we could see carnage. Worth keeping a watch announcement due soon.

DH you were always the dumb one here. Keep watching lol.

50p incoming.

Looks nicely plannerd Announcement to come.

Https://www.valirx.com/news/valirx-qa-session-dr-suzanne-dilly-and-dr-kevin-cox

https://www.brrmedia.co.uk/broadcasts-embed/65142ddf01d979c8a2ec78b2/valirx-qa-session/?popup=true#

VAL201 looks highly likely soon according to Suzy. That will be huge for both companies.

Looking forward to next month. Good RNS for a change and shows the potential on offer.

She needs to write a bloody good RNS full of potential showing future payments linked back to our tiny valuation not so much about science. A value adding RNS but is she capable of that. Not sure. Regardless it will still move.

Yes but if it happens what price will it open at? Trying buying at 40p. Bit like Synargen dropping from 200p to 10p. Did people get a chance to sell? No. People will not get a chance to buy.

Boom

No doubt has potential. Will keep a look out and if i see decent news may buy a decent amount. Looks like a book stock or bust as time goes by at this low valuation. Best wishes.

It is on my radar but although PYC has cash for now it will need to do another fundraise again next year. The problem is the low market cap and how it will raise cash in the future as it will need at least 1 million odd each time and with discounts it is difficult?

Don’t mean it is not a good time to buy.

Market conditions have been poor so pure luck but I can see big news coming and driving this north. Onwards and upwards.

AVCT has great potential. Given the market cap I am surprised it does not take advantage of buying cheap valuable assets that could be 10/100 times more in the next 1-2 years.

One that I am also invested in is Valirx. CLX has shown amazing potential if you watch the video and the peptide so far has shown great safety results. https://www.valirx.com/cytolytix-limited

As a preclinical drug it can fetch substantial upfront payments/milestones. Valirx also has few other decent compounds and a lab including imagen a recently purchased asset. GIven potential upside AVCT should also be looking at some cheap companies as assets which could bring huge value for shareholders in the next 12-18 months. This just is an example of the value on offer in this market.

Food for thought in this market and with a market cap where AVCT is it can take advantage in this market.

tdk knows more than you dumb ****. valirx has been 50p plus many times. don’t waste your time playing dumb.

Do the world a favour and disappear . Frustrated loser. Valirx is a fine investment and first revenue ever and lots more to come. You were saying no revenue is near. Cheap as chips at this Share price.

Stock 01- I cannot understand what you are trying to say. You don’t make much sense. Thanks and have a nice evening fella.

Maybe with 5 billion shares not 100 million. As simple as that.

This feels like a horror movie where the innocent person gets bitten by the vampire and converted. Anyone seen the film Evil Dead Rise? It feels like Metom has now been bitten by Porky so is now the villain.

In the end the vampire fails and dies.

Metom are you Nick? Please confirm?

Porky hi,

Can you confirm if this is a photo of you? https://twitter.com/jamesmaims/

Also away from Val do you have any hobbies?

What experience in business do you have?

You sit in your room day and night posting on LSE on a stock you claim to hold only 20 000 shares in. Your previous investments went to trash. Basic errors so please don’t tell us about business.

Give us names of companies to worked for? What positions and besides and regardless of what one knows it is all about intentions not always about knowledge.